Medicines Co. Puts Up $474M For Specialty Drugmaker
Global pharmaceutical company The Medicines Co. will pay up to $474 million to nab Rempex Pharmaceuticals Inc., a company that develops therapies to battle multidrug-resistant bacteria, according to a Wednesday statement....To view the full article, register now.
Already a subscriber? Click here to view full article